A Breakthrough

Non-Invasive Blood Based Test

That Can Detect Multiple Cancers at Early Stages in Asymptomatic Individuals With High Accuracy to Save Lives and Preserve Quality of Life.

The Civilizational Challenge

Cancer is a ticking time bomb globally. Every year about 18 million women and men are diagnosed with various cancers including carcinomas, sarcomas, neuroendocrine tumors, melanomas. These cancers are also associated with about 9 million deaths. This translates into roughly 34 cancer cases being detected and 18 cancer-related deaths every minute. Annually, these cancers contribute to:

  • ~4.1 million newly diagnosed cases and 1.8 million deaths in Europe (including the UK).
  • ~2.1 million newly diagnosed cases and 550,000 deaths in the US.
  • ~1.2 million newly diagnosed cases and 760,000 deaths in India.
  • Due to changes in lifestyle as well as other risk factors, these numbers are slated to increase in the future.

    What if

    you detect cancer early enough to save a life?

    Trucheck™-Breast

    Non-invasive blood test
    can detect early stages
    with high sensitivity.

    Trucheck™-Prostate

    Accurately identifies individuals
    with an underlying malignancy
    of the prostate.

    Trucheck™-Intelli

    Can enable early detection
    of multiple cancers in
    asymptomatic individuals.

    Our Scientific Approach

    • Circulating Tumor Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals.
    • Trucheck™ technology to detect and characterise CTCs has been proven through extensive clinical validations involving more than 40,000 participants.
    • The test is paradigm shift in cancer screening, as it does not involve radiation or invasive procedures. The test is performed at our world-class laboratory, which meets and exceeds all national and international standards.

    Our Scientific Approach

    • Circulating Tumor Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals.
    • Trucheck™ technology to detect and characterise CTCs has been proven through extensive clinical validations involving more than 40,000 participants.
    • The test is paradigm shift in cancer screening, as it does not involve radiation or invasive procedures. The test is performed at our world-class laboratory, which meets and exceeds all national and international standards.

    Advantages of Trucheck™

    Peace of Mind

    Cancer screening test for peace of mind!

    Non-Invasive

    Non-invasive and can be done without visiting a hospital or a screening centre.

    No Risks

    No risks usually associated with invasive procedures.

    No Wait Times

    No wait times for appointments

    70 Solid Organ Cancers

    Cost effective, provides screening for 70 solid organ cancers

    Avoid Unnecessary Procedures

    Helps avoid procedures that may be retrospectively found unnecessary

    We’re here to assist you

    If you have any questions or want to learn more, please contact us or visit our FAQs.